evidence human-specific mechanism diet antibody-mediated inflammation carcinoma progression abstract patients cancer circulating heterophile antibodies agglutinate animal red cells recognition mammalian cell surface sialic acid n-glycolylneuraminic acid neu num long considered oncofetal antigen humans humans genetically deficient neu num production metabolically accumulate neu num dietary sources red meats milk products mice human-like defect showed alternate pathway neu num synthesis normal humans express anti-neu num antibodies show human tumors accumulate neu num covalently attached multiple classes glycans paradox human tumor neu num accumulation face circulating anti-neu num antibodies hypothesized due facilitation tumor progression resulting low-grade chronic inflammation murine tumors expressing human-like levels neu num show accelerated growth syngeneic mice human-like neu num deficiency coincident induction anti-neu num antibodies increased infiltration inflammatory cells transfer polyclonal monospecific syngeneic mouse anti-neu num serum enhanced growth transplanted syngeneic tumors bearing human-like levels neu num tumors showing evidence antibody deposition enhanced angiogenesis chronic inflammation effects suppressed cyclooxygenase num inhibitor drug type reduce human carcinoma risk finally affinity-purified human anti-neu num antibodies accelerate growth neu num c-containing tumors neu num c-deficient mice data suggest human propensity develop diet-related carcinomas contributed local chronic inflammation resulting interaction metabolically-accumulated dietary neu num circulating anti-neu num antibodies 
